MYOV News and Press, Myovant Sciences Ltd. From 06/23/20

Fuwei Films (NASDAQ: FFHL ) +66%  on Q1 results . More news on: Fuwei Films (Holdings) Co., Ltd., Translate Bio, Inc., Recon Technology, Ltd., Stocks on the move, , Read more ...

Co-primary endpoints met with response rates of 74.5% for dysmenorrhea (menstrual pain) and 58.5% for non-menstrual pelvic pain (p-values < 0.0001) Women receiving relugolix combination therapy, on average, had a 73.3% reduction on the Numerical Rating Scale for dysmenorrhea from...

LONDON and NEW YORK, June 22, 2020 (GLOBE NEWSWIRE) -- Sumitovant Biopharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review, the New Drug Application (NDA) submitted by Myovant Sciences (NYSE: MYOV), for once-daily, oral rel...

Gainers:  APYX +35.1% . ALLO +4.3% . NRZ +3.4% . MYOV +2.9% . CMCL +2.8% . More news on: Apyx Medical Corporation, Allogene Therapeutics, Inc., New Residential Investment Corp., Stocks on the move, , Read more ...

BASEL, Switzerland, June 22, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that it will host a webcast and conference call to discuss top-line results from the Phase 3 SPIRIT 1 study of onc...

Priority Review status expected to accelerate review, with a target FDA action date of December 20, 2020 BASEL, Switzerland, June 22, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced tha...

Are These 2 Best Health Care Stocks On Your Watchlist This Month? Health care stocks have been some of the best-performing stocks since the market bottomed out in March. With a lot of coronavirus developments in play, this sector is racing to come up with a vaccine or treatment. The world ...

Overview Urovant Sciences (NASDAQ: UROV ) is a clinical stage biopharmaceutical company focused on the development and commercialization of its lead product candidate, vibegron, an oral, once-daily, small molecule beta-3 agonist, for the treatment of overactive bladder (OAB), OAB in men...

NEW YORK and LONDON , June 1, 2020 /PRNewswire/ -- Sumitovant Biopharma Ltd. announced today that Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, and one of five healthcare companies in the Sumitovant family of companies, has su...

Gainers: Cemtrex (NASDAQ: CETX )  +209% . More news on: Cemtrex, Inc., Digital Ally, Inc., Allied Esports Entertainment Inc., Stocks on the move, , Read more ...